Skip to main content
VCbacked
Log inGet Started

Caristo Diagnostics

Oxford, United Kingdom

Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.

$150K raised
Sep 2024
Venture - Series Unknown
BiopharmaHealth CareHealth DiagnosticsMedical Device

Top Investors

Oxford Science EnterprisesLongwall VentureBGF VenturesOxford University InnovationHeartX

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Caristo Diagnostics

How much funding has Caristo Diagnostics raised?
Caristo Diagnostics has raised $150K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
Who are Caristo Diagnostics's investors?
Caristo Diagnostics's investors include Oxford Science Enterprises, Longwall Venture, BGF Ventures, Oxford University Innovation, HeartX.
Where is Caristo Diagnostics headquartered?
Caristo Diagnostics is headquartered in Oxford, United Kingdom.
What does Caristo Diagnostics do?
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
What stage is Caristo Diagnostics at?
Caristo Diagnostics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Caristo Diagnostics — Funding & Investors." VCBacked, September 30, 2024, https://www.vcbacked.co/company/caristo-diagnostics. Accessed June 3, 2026.
APA
VCBacked. (2024). Caristo Diagnostics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/caristo-diagnostics
Wikipedia (cite web)
{{cite web |title=Caristo Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/caristo-diagnostics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego